Growth Metrics

EyePoint Pharmaceuticals (EYPT) Shares Outstanding (Diluted Average): 2010-2012

Historic Shares Outstanding (Diluted Average) for EyePoint Pharmaceuticals (EYPT) over the last 3 years, with Jun 2012 value amounting to $20.8 million.

  • EyePoint Pharmaceuticals' Shares Outstanding (Diluted Average) rose 6.68% to $20.8 million in Q2 2012 from the same period last year, while for Jun 2012 it was $20.8 million, marking a year-over-year increase of 6.68%. This contributed to the annual value of $20.8 million for FY2012, which is 6.68% up from last year.
  • As of FY2012, EyePoint Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $20.8 million, which was up 6.68% from $19.5 million recorded in FY2011.
  • EyePoint Pharmaceuticals' 5-year Shares Outstanding (Diluted Average) high stood at $20.8 million for FY2012, and its period low was $18.9 million during FY2010.
  • Over the past 3 years, EyePoint Pharmaceuticals' median Shares Outstanding (Diluted Average) value was $19.5 million (recorded in 2011), while the average stood at $19.7 million.
  • Data for EyePoint Pharmaceuticals' Shares Outstanding (Diluted Average) shows a peak YoY increased of 6.68% (in 2012) over the last 5 years.
  • Yearly analysis of 3 years shows EyePoint Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $18.9 million in 2010, then increased by 3.14% to $19.5 million in 2011, then increased by 6.68% to $20.8 million in 2012.